(Q36395096)

13 August 2017

1 reference

title

Therapy Insight: bladder dysfunction associated with multiple sclerosis (English)

1 reference

13 August 2017

0 references

Vinay Kalsi

1

1 reference

13 August 2017

Clare J Fowler

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

13 August 2017

published in

Nature Reviews Urology

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

492-501

1 reference

Multiple sclerosis and the urologist

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Brain responses to changes in bladder volume and urge to void in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Human brain region response to distention or cold stimulation of the bladder: a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Brain activation during micturition in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Central pathways controlling micturition and urinary continence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Novel role for alpha1-adrenergic receptor subtypes in lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Intravesical capsaicin for neurogenic bladder dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Intravesical instillation of capsaicin in urology: A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Vanilloid receptor and detrusor instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Bladder, Bowel, and Sexual Dysfunction in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

BLADDER DYSFUNCTION IN MULTIPLE SCLEROSIS.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Human Brain Region Response to Distention or Cold Stimulation of the Bladder: A Positron Emission Tomography Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

A PET study on brain control of micturition in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Mechanisms underlying the recovery of urinary bladder function following spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

The basis for drug treatment of the overactive bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

The changing neurourologic pattern of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Urodynamic pattern changes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Relationship between neurological and urological status in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Tolterodine: a review of its use in the treatment of overactive bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Efficient treatment of neurogenic bladder disorders in multiple sclerosis with initial intermittent catheterization and ultrasound-controlled training

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Investigation of the neurogenic bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis)

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Bladder and sphincter behavior in patients with spinal cord lesions

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Do Alpha-Blockers Have a Role in Lower Urinary Tract Dysfunction in Multiple Sclerosis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Emptying the paralysed bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

The 'Queen Square bladder stimulator': a device for assisting emptying of the neurogenic bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Lower abdominal pressure versus external bladder stimulation to aid bladder emptying in multiple sclerosis: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Assessment of the safety of regular DDAVP therapy in primary nocturnal enuresis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Prevalence of conditions potentially associated with lower urinary tract symptoms in men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Augmentation and substitution enterocystoplasty

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Ileocecocystoplasty for the management of refractory neurogenic bladder: surgical technique and urodynamic findings

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

LONG-TERM RESULTS OF SACRAL NERVE STIMULATION (S3) FOR THE TREATMENT OF NEUROGENIC REFRACTORY URGE INCONTINENCE RELATED TO DETRUSOR HYPERREFLEXIA

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Management of the neuropathic bladder by suprapubic catheterisation

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0323

7 January 2021

Identifiers

DOI

10.1038/NCPURO0323

1 reference

Dimensions Publication ID

13 August 2017

1030493835

0 references

1 reference